Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Oligoproline effects on polyglutamine conformation and aggregation.

Anusri Bhattacharyya1, Ashwani K Thakur, Veronique M Chellgren

  • 1Graduate School of Medicine, University of Tennessee, 1924 Alcoa Highway, Knoxville, TN 37920, USA.

Journal of Molecular Biology
|December 3, 2005
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Unravelling γD-crystallin aggregation pathway to understand cataract formation using fluorescence correlation spectroscopy.

Molecular vision·2025
Same author

Pan-Amyloid Reactive Peptides p5+14 and p5R Exhibit Specific Charge-Dependent Binding to Glycosaminoglycans.

Pharmaceuticals (Basel, Switzerland)·2025
Same author

Unravelling γD-crystallin aggregation pathway to understand cataract formation using fluorescence correlation spectroscopy.

Molecular vision·2025
Same author

Enzymatic Desialylation Enables Reliable Charge Variant Characterization of Highly Glycosylated and Sialylated Fc Fusion Proteins.

ACS pharmacology & translational science·2025
Same author

Disruption of fibrillar assemblies of L-phenylalanine using polyphenol-passivated nanocarbon as a potential therapeutic strategy against phenylketonuria.

Organic & biomolecular chemistry·2025
Same author

Neutrophils enhance the clearance of systemic amyloid deposits in a murine amyloidoma model.

Frontiers in immunology·2024

Adding a P10 sequence to polyglutamine (polyGln) significantly reduces amyloid aggregate formation in neurological disease models. This finding offers new insights into polyGln aggregation and potential therapeutic strategies for diseases like Huntington's disease.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Molecular Biology

Background:

  • Nine neurological diseases are linked to expanded CAG repeats, causing polyglutamine (polyGln) expansion in proteins.
  • The protein context and sequence surrounding polyGln influence its aggregation and disease pathology.
  • Huntington's disease (HD) involves polyGln expansion in huntingtin protein, followed by an oligoproline region.

Purpose of the Study:

  • To investigate the effect of C-terminal oligoproline sequences on polyglutamine (polyGln) aggregation.
  • To determine the optimal length and placement of oligoproline sequences for suppressing polyGln aggregation.
  • To explore the mechanism by which oligoproline sequences modulate polyGln aggregation and its implications for neurological diseases.

Main Methods:

Related Experiment Videos

  • Synthesis of peptides containing polyglutamine (polyGln) sequences with varying C-terminal oligoproline extensions.
  • Analysis of amyloid-like aggregate formation using techniques to measure aggregation rate and stability.
  • Circular dichroism spectroscopy to assess changes in peptide secondary structure.
  • Testing the effect of C-terminal P10 sequence on Abeta fibril formation.

    • Main Results:

    • A C-terminal P10 sequence significantly decreased the rate and stability of polyGln amyloid-like aggregate formation.
    • The suppressive effect was maintained with P6 but lost with P3 oligoproline sequences.
    • Spacer sequences between polyGln and P10 did not abolish the effect, but N-terminal or tethered P10 sequences were ineffective.
    • P10 addition altered the circular dichroism spectra of polyGln peptides, suggesting stabilization of an aggregation-incompetent monomer conformation.
    • The P10 sequence's effect on aggregation was transportable, modulating Abeta fibril formation.

    Conclusions:

    • C-terminal oligoproline sequences, particularly P10, can effectively suppress polyglutamine (polyGln) aggregation.
    • The structural context and placement of oligoproline sequences are critical for their inhibitory effect.
    • These findings suggest a potential therapeutic strategy for polyGln-repeat neurological diseases by modulating protein aggregation.